# M1610 Paper-Route Diagnostic-Complete Bounded Replay Result Audit

## Summary

M1610 audits the M1609 diagnostic-complete bounded replay public pass before any
candidate materialization, corpus export, training, PPO, or promotion decision.

Decision:

```text
diagnostic_complete_bounded_replay_audit_admit_materialization_design
```

M1609 is a real public proof pass: the primary clean contour is preserved and
the diagnostic/control surface is no longer under-sampled. The next step can be
design-only materialization planning. It must not materialize candidates or
export a training corpus yet.

## Evidence

M1609 replayed:

```text
primary_replay_directed_pair_count: 144
diagnostic_replay_directed_pair_count: 232
classified_directed_pair_count: 376
intervention_row_count: 3008
variant_count: 8
```

Primary contour evidence:

```text
primary_clean_directed_pair_count: 39
primary_clean_source_edge_count: 4
max_primary_clean_source_edge_share: 0.3333333333333333
endpoint_neighbor_primary_count: 0
negative_diagnostic_primary_count: 0
mixed_diagnostic_primary_count: 0
```

Diagnostic/control evidence:

```text
diagnostic_reason_count: 3
diagnostic_clean_directed_pair_count: 2
diagnostic_clean_share: 0.008620689655172414
diagnostic_dominated_or_control_count: 81
```

Replay health and guardrails:

```text
anchor_replay_failure_count: 0
invalid_directed_pair_count: 0
required_variant_coverage_complete: true
guardrail_violation_count: 0
passes_evidence_quality_targets: true
passes_public_smoke_gates: true
null_result_classification: contour_aware_bounded_replay_public_pass
```

## Supported Claims

M1610 supports:

```text
M1609 fixed the M1605 capped-diagnostic shortfall;
the M1602 primary clean contour survives full diagnostic replay;
the full diagnostic replay preserves enough dominated/control evidence to keep the selector honest;
the public-pass rows are eligible for design-only materialization planning;
the next step should remain gated and auditable.
```

## Unsupported Claims

M1610 does not support:

```text
candidate materialization;
training corpus export;
PPO continuation;
checkpoint promotion;
private-holdout evidence;
paper-level self-identification;
level3 anticipatory self-identification;
broad distribution generalization.
```

## Failure Taxonomy

```text
none
```

The original M1605 diagnostic-control failure is resolved by M1609. Residual
risk remains public-gate overfit, not a failed M1609 gate.

## Public-Gate Overfit Risk

Risk:

```text
medium_high
```

Reasons:

```text
the pass is still on public M1602-derived rows;
the primary clean evidence is useful but narrow;
diagnostic controls protect selector honesty, not broad scenario generalization;
no private holdout or distribution-level benchmark was used.
```

Mitigation for the next step:

```text
design materialization before executing it;
keep primary and diagnostic rows separate;
preserve source-edge balance and exact replay ids;
require a materialization audit before corpus export or training;
continue blocking PPO, promotion, private holdout, actor-input changes, and self-ID overclaims.
```

## Route Decision

Admit design-only materialization planning:

```text
m1611-paper-route-contour-aware-candidate-materialization-design
```

M1611 should specify how candidate artifacts would be materialized from M1609
without executing materialization. It should include row eligibility, source
edge limits, diagnostic exclusion/guardrail handling, exact replay-id
preservation, required artifacts, and the audit that must follow any later
implementation.

## Guardrails

```text
replay_started: false in M1610
history_interventions_executed: false in M1610
candidate_materialized: false
training_started: false
evaluation_started: false
ppo_used: false
promoted: false
private_holdout_used: false
actor_input_contract_changed: false
training_corpus_exported: false
labels_enter_actor_input: false
level3_self_id_claim_made: false
```

## Next

```text
m1611-paper-route-contour-aware-candidate-materialization-design
```
